These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10967579)

  • 21. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
    Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
    Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collection of hematopoietic stem cells from patients with autoimmune diseases.
    Burt RK; Fassas A; Snowden J; van Laar JM; Kozak T; Wulffraat NM; Nash RA; Dunbar CE; Arnold R; Prentice G; Bingham S; Marmont AM; McSweeney PA
    Bone Marrow Transplant; 2001 Jul; 28(1):1-12. PubMed ID: 11498738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
    Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
    Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
    López-Holgado N; Pata C; Villarón E; Sánchez-Guijo F; Alberca M; Martín A; Corral M; Sánchez-Abarca I; Pérez-Simón JA; San Miguel JF; del Cañizo MC
    Haematologica; 2005 Mar; 90(3):353-9. PubMed ID: 15749668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
    Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
    Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
    Vogel W; Kopp HG; Kanz L; Einsele H
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hematopoietic progenitor in bone marrow and peripheral blood.
    Messner HA
    Stem Cells; 1998; 16 Suppl 1():93-6. PubMed ID: 11012151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH; Schulman KA; Buckner CD
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive parameters for granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.
    Okano A; Ashihara E; Shimazaki C; Uchiyama H; Inaba T; Taniguchi K; Maekawa T; Taniwaki M
    J Clin Apher; 2008; 23(6):171-7. PubMed ID: 18988229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF.
    Meldgaard Knudsen L; Jensen L; Gaarsdal E; Nikolaisen K; Johnsen HE
    Bone Marrow Transplant; 2000 Oct; 26(7):717-22. PubMed ID: 11042651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
    Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
    Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
    Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
    Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
    Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H; Gu X; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood stem cell procurement: donor safety issues.
    Anderlini P; Przepiorka D; Körbling M; Champlin R
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation.
    Bogunia-Kubik K; Gieryng A; Dlubek D; Lange A
    Bone Marrow Transplant; 2009 Sep; 44(5):273-8. PubMed ID: 19252530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
    Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.